Drug industry to announce revised code on marketing
Gifts that drug makers have long showered on doctors will be banned from pharmaceutical marketing campaigns under new voluntary guidelines titled the "Code on Interactions with Health Care Professionals." The guidelines will ask the chief executives of large drug makers to certify in writing that "they have policies and procedures in place to foster compliance with the code." The code, however, provides no definite limits on the millions of dollars spent on speaking and consulting arrangements that drug makers have forged with doctors. The code was written by the Pharmaceutical Research and Manufacturers of America.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- 3 Traits Personality Assessments Can't Reveal
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC